Citations for
1OPHN1
Oligophrenin-1 regulates number, morphology and synaptic properties of adult-born inhibitory interneurons in the olfactory bulb.
Redolfi N, Galla L, Maset A, Murru L, Savoia E, Zamparo I, Gritti A, Billuart P, Passafaro M, Lodovichi C.
Hum Mol Genet 25(23):5198-5211. doi: 10.1093/hmg/ddw340. 2016
2OPHN1, ROCK1
Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.
Compagnucci C, Barresi S, Petrini S, Billuart P, Piccini G, Chiurazzi P, Alfieri P, Bertini E, Zanni G.
Stem Cells Transl Med 5(7):860-9. doi: 10.5966/sctm.2015-0303. Epub 2016 May 9. 2016
3OPHN1
Oligophrenin-1 Connects Exocytotic Fusion to Compensatory Endocytosis in Neuroendocrine Cells.
Houy S, Estay-Ahumada C, Croisé P, Calco V, Haeberlé AM, Bailly Y, Billuart P, Vitale N, Bader MF, Ory S, Gasman S.
J Neurosci 35(31):11045-55. doi: 10.1523/JNEUROSCI.4048-14.2015. 2015
4OPHN1
Loss of oligophrenin1 leads to uncontrolled Rho activation and increased thrombus formation in mice.
Fotinos A, Klier M, Gowert NS, Münzer P, Klatt C, Beck S, Borst O, Billuart P, Schaller M, Lang F, Gawaz M, Elvers M.
J Thromb Haemost 13(4):619-30. doi: 10.1111/jth.12834. Epub 2015 Jan 29. 2015
5HOMER1, OPHN1
The X-linked mental retardation protein OPHN1 interacts with Homer1b/c to control spine endocytic zone positioning and expression of synaptic potentiation.
Nakano-Kobayashi A, Tai Y, Nadif Kasri N, Van Aelst L.
J Neurosci 34(26):8665-71. doi: 10.1523/JNEUROSCI.0894-14.2014. 2014
6OPHN1
Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.
Goto K, Oue N, Hayashi T, Shinmei S, Sakamoto N, Sentani K, Teishima J, Matsubara A, Yasui W.
Pathobiology 81(4):190-8. doi: 10.1159/000363345. Epub 2014 Aug 27. 2014
7OPHN1
Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development.
Barresi S, Tomaselli S, Athanasiadis A, Galeano F, Locatelli F, Bertini E, Zanni G, Gallo A.
PLoS One 9(3):e91351. doi: 10.1371/journal.pone.0091351. eCollection 2014. 2014
8MRX60, OPHN1
A novel in-frame deletion affecting the BAR domain of OPHN1 in a family with intellectual disability and hippocampal alterations.
Santos-Rebouças CB, Belet S, Guedes de Almeida L, Ribeiro MG, Medina-Acosta E, Bahia PR, Alves da Silva AF, Lima dos Santos F, Borges de Lacerda GC, Pimentel MM, Froyen G.
Eur J Hum Genet 22(5):644-51. doi: 10.1038/ejhg.2013.216. Epub 2013 Oct 9. 2014
9CDC42, OPHN1, RAC1, RHOA
The GRAF family member oligophrenin1 is a RhoGAP with BAR domain and regulates Rho GTPases in platelets.
Elvers M, Beck S, Fotinos A, Ziegler M, Gawaz M.
Cardiovasc Res 94(3):526-36. doi: 10.1093/cvr/cvs079. Epub 2012 Feb 1. 2012
10OPHN1
Oligophrenin-1 (Ophn1) is expressed in mouse retinal vessels.
Sel S, Kaiser M, Nass N, Trau S, Roepke A, Storsberg J, Hampel U, Paulsen F, Kalinski T.
Gene Expr Patterns 12(1-2):63-7. doi: 10.1016/j.gep.2011.11.003. Epub 2011 Nov 20. 2012
11MRX60, OPHN1
Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.
Al-Owain M, Kaya N, Al-Zaidan H, Al-Hashmi N, Al-Bakheet A, Al-Muhaizea M, Chedrawi A, Basran RK, Milunsky A.
Clin Genet 79(4):363-70. doi: 10.1111/j.1399-0004.2010.01462.x. 2011
12MRX60, OPHN1
Novel intragenic deletion in OPHN1 in a family causing XLMR with cerebellar hypoplasia and distinctive facial appearance.
Al-Owain M, Kaya N, Al-Zaidan H, Al-Hashmi N, Al-Bakheet A, Al-Muhaizea M, Chedrawi A, Basran R, Milunsky A.
Clin Genet lin Genet. 2010 May 7. [Epub ahead of print]PMID: 20528889 2010
13MRX60, OPHN1
The Rho-linked mental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors.
Nadif Kasri N, Nakano-Kobayashi A, Malinow R, Li B, Van Aelst L.
Genes Dev 23(11):1289-302.PMID: 19487570 2009
14OPHN1
The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1.
Nakano-Kobayashi A, Kasri NN, Newey SE, Van Aelst L.
Curr Biol 19(13):1133-9. Epub 2009 May 28.PMID: 19481455 2009
15OPHN1
Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation.
Khelfaoui M, Pavlowsky A, Powell AD, Valnegri P, Cheong KW, Blandin Y, Passafaro M, Jefferys JG, Chelly J, Billuart P.
Hum Mol Genet 18(14):2575-83. Epub 2009 Apr 28.PMID: 19401298 2009
16OPHN1
Deletion of the OPHN1 gene detected by aCGH.
Madrigal I, Rodríguez-Revenga L, Badenas C, Sánchez A, Milà M.
J Intellect Disabil Res 52(Pt 3):190-4.PMID: 18261018 2008
17CFNS, EFNB1, OPHN1, PJA1, EDA
Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome.
Wieland I, Weidner C, Ciccone R, Lapi E, McDonald-McGinn D, Kress W, Jakubiczka S, Collmann H, Zuffardi O, Zackai E, Wieacker P.
Clin Genet 72(6):506-16. Epub 2007 Oct 16. 2007
18ACSL4, AFF2, AGTR2, ARHGEF6, ARX, ATRX, DLG3, ESMR, FTSJ1, GDI1, IL1RAPL1, KDM5C, MECP2, MRX68, MRX89, MRX90, MRXS31, NLGN3, NLGN4X, OPHN1, PQBP1, RPS6KA3, RTTM, SLC16A2, SLC6A8, SYN1, TSPAN7, ZNF41
X linked mental retardation: a clinical guide.
Raymond FL.
J Med Genet 43(3):193-200. Epub 2005 Aug 23. 2006
19OPHN1, MRX60
Delineation of the clinical phenotype associated with OPHN1 mutations based on the clinical and neuropsychological evaluation of three families.
Chabrol B, Girard N, N'Guyen K, Gerard A, Carlier M, Villard L, Philip N.
Am J Med Genet A 138(4):314-7. 2005
20OPHN1, MRX60
Specific clinical and brain MRI features in mentally retarded patients with mutations in the Oligophrenin-1 gene.
des Portes V, Boddaert N, Sacco S, Briault S, Maincent K, Bahi N, Gomot M, Ronce N, Bursztyn J, Adamsbaum C, Zilbovicius M, Chelly J, Moraine C.
Am J Med Genet 124A(4):364-71. 2004
21OPHN1, MRX60
The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis.
Govek EE, Newey SE, Akerman CJ, Cross JR, Van der Veken L, Van Aelst L.
Nat Neurosci 7(4):364-72. Epub 2004 Mar 14. 2004
22MRX60, OPHN1
Oligophrenin 1 (OPHN1) gene mutation causes syndromic X-linked mental retardation with epilepsy, rostral ventricular enlargement and cerebellar hypoplasia.
Bergmann C, Zerres K, Senderek J, Rudnik-Schoneborn S, Eggermann T, Hausler M, Mull M, Ramaekers VT.
Brain 126(Pt 7):1537-44. Epub 2003 May 21. Review. 2003
23OPHN1
The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain.
Fauchereau F, Herbrand U, Chafey P, Eberth A, Koulakoff A, Vinet MC, Ahmadian MR, Chelly J, Billuart P.
Mol Cell Neurosci 23(4):574-86. 2003
24OPHN1
Significant overexpression of oligophrenin-1 in colorectal tumors detected by cDNA microarray analysis.
Pinheiro NA, Caballero OL, Soares F, Reis LF, Simpson AJ.
Cancer Lett 172(1):67-73. 2001
25OPHN1
Determination of the gene structure of human oligophrenin-1 and identification of three novel polymorphisms by screening of DNA from 164 patients with non-specific X-linked mental retardation.
Billuart P, Chelly J, Carrie A, Vinet M, Couvert P, McDonell N, Zemni R, Kahn A, Moraine C, Beldjord C, Bienvenu T.
Ann Genet 43(1):5-9. 2000
26EFNB1, HEPH, MSN, OPHN1
Large-insert clone/STS contigs in Xq11-q12, spanning deletions in patients with androgen insensitivity and mental retardation.
Schueler MG, Higgins AW, Nagaraja R, Tentler D, Dahl N, Gustashaw K, Willard HF.
Genomics 66(1):104-9. 2000
27OPHN1, FGD1, FMR1, GDI1, PAK3, RPS6KA3, MRX1
Breakthroughs in molecular and cellular mechanisms underlying X-linked mental retardation.
Chelly J.
Hum Mol Genet 8(10):1833-8. Review. 1999
28OPHN1, MRX60
Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation.
Billuart P, et al.
Nature 392 : 923-926. 1998